ABBY STRICKLAND: Open Payments
NPI 1639204415 · MARIANNA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 10 payments from 8 companies in 2025. Trend: 2023 $516 · 2024 $0 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $152 |
| Neurocrine BioSciences, Inc. | 1 | $115 |
| Otsuka America Pharmaceutical, Inc. | 1 | $113 |
| Novo Nordisk Inc | 1 | $106 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $79 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: FANAPT, INGREZZA, REXULTI, Wegovy, CAPLYTA, Quviviq, Qelbree.
Industry payments across FL — which companies pay providers there.
